Clinical Trial Update: Efficacy of Cloxacillin and Fosfomycin Combination Versus Cloxacillin Monotherapy in Patients With MSSA Bacteremia [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating efficacy of a cloxacillin and fosfomycin combination versus cloxacillin alone in MSSA bacteremia; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methicillin-susceptible Staphylococcus Aureus Septicemia

Drugs mentioned

• Fosfomycin (Fosfomycin)
• cloxacillin (cloxacillin)

Snippet

Sponsor: Miquel Pujol | Conditions: Methicillin Susceptible Staphylococcus Aureus Septicemia | Phase 4 | Status: TERMINATED